Substance Use & Misuse · 2008 · 130 citations · 15 references
PharmacyPharmacologyClinical PharmacologyDrug Utilization ReviewSubstance Use DisordersDrug EvaluationDrug Overdose ManagementDrug Overdose PreventionOverdose ManagementOverdose PreventionSubstance Abuse PreventionCommunity Naloxone DistributionDrug Overdose MortalityIntravenous Naloxone AdministrationNaloxone ImplementationOpioid Overdose EducationOpioid Overdose ManagementOverdose Mortality ReductionOverdose Prevention Training
Naloxone, an opioid antagonist that can prevent overdose deaths, has only recently been prescribed to drug users in a handful of U.S. jurisdictions, including New York City. This report presents the first systematic evaluation of large‑scale naloxone distribution to injection drug users in the United States. In 2005, 122 injection‑drug users attending syringe‑exchange programs in New York City were trained in the SKOOP overdose‑prevention curriculum, prescribed naloxone, and completed a questionnaire on overdose experience and naloxone use.
Naloxone, an opiate antagonist that can avert opiate overdose mortality, has only recently been prescribed to drug users in a few jurisdictions (Chicago, Baltimore, New Mexico, New York City, and San Francisco) in the United States. This report summarizes the first systematic evaluation of large-scale naloxone distribution among injection drug users (IDUs) in the United States. In 2005, we conducted an evaluation of a comprehensive overdose prevention and naloxone administration training program in New York City. One hundred twenty-two IDUs at syringe exchange programs (SEPs) were trained in Skills and Knowledge on Overdose Prevention (SKOOP), and all were given a prescription for naloxone by a physician. Participants in SKOOP were over the age of 18, current participants of SEPs, and current or former drug users. Participants completed a questionnaire that assessed overdose experience and naloxone use. Naloxone was administered 82 times; 68 (83.0%) persons who had naloxone administered to them lived, and the outcome of 14 (17.1%) overdoses was unknown. Ninety-seven of 118 participants (82.2%) said they felt comfortable to very comfortable using naloxone if indicated; 94 of 109 (86.2%) said they would want naloxone administered if overdosing. Naloxone administration by IDUs is feasible as part of a comprehensive overdose prevention strategy and may be a practicable way to reduce overdose deaths on a larger scale.
15
Morbidity and Mortality Weekly Report
Wilderness and Environmental Medicine · 2010 · 3K citations
Thomas B. Croat, P. Kinslow · 2007 · 1.1K citations
Prescribing Naloxone to Actively Injecting Heroin Users
Sarz Maxwell, D Bigg, Karen Stanczykiewicz et al. · Journal of Addictive Diseases · 2006 · 243 citations